Skip to main content
Log in

Blood product use during orthotopic liver transplantation

  • Correspondence
  • Published:
Canadian Journal of Anesthesia Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Marcel RJ, Stegall WC, Suit CT, et al. Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation. Anesth Analg 1996; 82: 1122–5.

    CAS  PubMed  Google Scholar 

  2. Cacciarelli TV, Keeffe EB, Moore DH, et al. Primary liver transplantation without transfusion of red blood cells. Surgery 1996; 120: 698–704.

    Article  CAS  PubMed  Google Scholar 

  3. Ramos E, Dalmau A, Sabate A, et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction requirements, and measures to reduce them. Liver Transpl 2003; 9: 1320–7.

    Article  PubMed  Google Scholar 

  4. Baldry C, Backman SB, Metrakos, P, Tchervenkov J, Barkun J, Moore, A. Liver transplantation in a Jehovah’s Witness with ankylosing spondylitis. Can J Anesth 2000, 47: 642–6.

    Article  CAS  PubMed  Google Scholar 

  5. Reyle-Hahn M, Rossaint R. Coagulation techniques are not important in directing blood product tansfusion during liver transplantation. Liver Transpl Surg 1997; 6: 659–63.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shan, W.L.P., Barkun, J., Metrakos, P. et al. Blood product use during orthotopic liver transplantation. Can J Anesth 51, 1045–1046 (2004). https://doi.org/10.1007/BF03018496

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03018496

Keywords

Navigation